Jodrell, D. I., Bowman, A., Rye, R., Byrne, B., Boddy, A., Rafi, I., . . . Clendeninn, N. J. (1999). A phase I study of the lipophilic thymidylate synthase inhibitor Thymitaq™ (nolatrexed dihydrochloride) given by 10-day oral administration. Nature Publishing Group.

Jodrell, D I., A. Bowman, R. Rye, B. Byrne, A. Boddy, I. Rafi, G A. Taylor, A. Johnston, and N J. Clendeninn. A Phase I Study of the Lipophilic Thymidylate Synthase Inhibitor Thymitaq™ (nolatrexed Dihydrochloride) Given By 10-day Oral Administration. Nature Publishing Group, 1999.

Jodrell, D I., et al. A Phase I Study of the Lipophilic Thymidylate Synthase Inhibitor Thymitaq™ (nolatrexed Dihydrochloride) Given By 10-day Oral Administration. Nature Publishing Group, 1999.